Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience

被引:20
|
作者
Hectors, Stefanie J. [1 ]
Wagner, Mathilde [1 ,2 ]
Besa, Cecilia [1 ,3 ]
Huang, Wei [4 ]
Taouli, Bachir [1 ,5 ]
机构
[1] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA
[2] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, UPMC,Dept Radiol, 47-83 Blvd Hop, F-75013 Paris, France
[3] Pontificia Univ Catolica Chile, Sch Med, Dept Radiol, Santiago, Chile
[4] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, 3181 SW Sam Jackson Pk,Rd L452, Portland, OR 97239 USA
[5] Icahn Sch Med Mt Sinai, Dept Radiol, 1 Gustave L Levy Pl, New York, NY 10029 USA
关键词
APPARENT DIFFUSION-COEFFICIENT; PERFUSION QUANTIFICATION; MRI; PET; REPRODUCIBILITY; FLOW;
D O I
10.1155/2018/5638283
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose. To compare multiparametric (mp) FDG-PET/MRI metrics between hepatocellular carcinoma (HCC) and liver parenchyma and to assess the correlation between mpMRI and FDG-PET standard uptake values (SUVs) in liver parenchyma and HCC. Methods. This prospective, institutional review board-approved study enrolled 15 patients (M/F 12/3; mean age 61 y) with HCC. mpMRI including blood-oxygen-level-dependent (BOLD) MRI, intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI), and dynamic contrast-enhanced-(DCE-) MRI was performed simultaneously with F-18-FDG-PET on a 3T PET/MRI hybrid system. Quantitative BOLD, IVIM and DCE-MRI parameters (Tofts model (TM) and shutter-speed model (SSM)), and PET parameters (SUVmean and SUVmax) were quantified and compared between HCC lesions and liver parenchyma using Wilcoxon signed-rank tests. SUV ratios between HCCs and liver were also calculated (SUVmean T/L and SUVmax T/L). Diagnostic performance of (combined) mp-PET/MRI parameters for characterization of HCC was assessed using ROC analysis. Spearman correlations between PET and mpMRI parameters in HCC tumors and liver parenchyma were evaluated. Results. 21 HCC lesions (mean size 4.0 +/- 2.4 cm; range 2-13 cm) were analyzed. HCCs exhibited significantly higher arterial fraction (from DCE-MRI) and lower R-2* pre-O-2 and post-O-2 (from BOLD-MRI) versus liver parenchyma (P < 0.032). The highest diagnostic performance for differentiation between HCC and liver parenchyma was achieved for combined ART SSM and R-2* post-O-2 (AUC=0.91). SUVmax showed reasonable performance for differentiation of HCC versus liver (AUC. 0.75). In HCC, DCE-MRI parameters K-trans (TM and SSM) and v(e) TM exhibited significant negative correlations with SUVmax T/L (r ranges from -0.624 to -0.566; FDR-adjusted P < 0.050). Conclusions. Despite the observed reasonable diagnostic performance of FDG-PET SUVmax for HCC detection and several significant correlations between FDG-PET SUV and DCE-MRI parameters, FDG-PET did not provide clear additional value for HCC characterization compared to mpMRI in this pilot study.
引用
下载
收藏
页数:10
相关论文
共 50 条
  • [21] Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinoma
    Kaissis, Georgios A.
    Lohoefer, Fabian K.
    Hoerl, Marie
    Heid, Irina
    Steiger, Katja
    Munoz-Alvarez, Kim Agnes
    Schwaiger, Markus
    Rummeny, Ernst J.
    Weichert, Wilko
    Paprottka, Philipp
    Braren, Rickmer
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 124
  • [22] FDG-PET/MRI in alveolar echinococcosis
    Loetsch, Felix
    Waneck, Fredrik
    Auer, Herbert
    Kaczirek, Klaus
    Karanikas, Georgios
    Ramharter, Michael
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 64 : 67 - 68
  • [23] Evolving role of FDG-PET/CT and FDG-PET/MRI for assessment of multiple myeloma
    Bural, Gonca
    Torigian, Drew
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [24] Use of MRI/FDG-PET image fusion for the detection of pancreatic carcinoma
    Amthauer, H
    Lopez-Hanninen, E
    Bohmig, M
    Ruf, J
    Lehmkuhl, L
    Denecke, T
    Bachofner, A
    Rosewicz, S
    Felix, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S334 - S334
  • [25] FDG-PET evaluation of vaginal carcinoma
    Lamoreaux, WT
    Grigsby, PW
    Dehdashti, F
    Zoberi, I
    Powell, MA
    Gibb, RK
    Rader, JS
    Mutch, DG
    Siegel, BA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03): : 733 - 737
  • [26] INITIAL EXPERIENCE OF WHOLE-BODY FDG-PET STUDIES WITH ATTENUATION CORRECTION
    DOGAN, AS
    HICHWA, RD
    RICHMOND, JC
    KOEPPEL, JA
    PONTO, LLB
    KIRCHNER, PT
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P104 - P104
  • [27] PET Pronostic Biomarkers Exploratory Analyses About Initial FDG-PET In Patients With Anal Carcinoma
    Testard, A.
    Le Thiec, M.
    Ferrer, L.
    Guillerminet, C.
    Morel, O.
    Kraeber-Bodere, F.
    Rousseau, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S466 - S466
  • [28] QUANTITATIVE MRI AND FDG-PET/CT IMAGING OF TUMOURAL HETEROGENEITY IN CERVICAL CARCINOMA
    Connolly, B.
    Hwang, D.
    Rao, A.
    Wegner, E. A.
    Moses, D.
    Shon, I. Ho
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 39 - 39
  • [29] Autoimmune epilepsy: findings on MRI and FDG-PET
    Guerin, Julie
    Watson, Robert E.
    Carr, Carrie M.
    Liebo, Greta B.
    Kotsenas, Amy L.
    BRITISH JOURNAL OF RADIOLOGY, 2018, 92 (1093):
  • [30] QUANTITATIVE ASSESSMENT OF MICROVASCULAR INVASION IN HEPATOCELLULAR CARCINOMA USING PREOPERATIVE DCP AND FDG-PET
    Seo, Satoru
    Yoh, Tomoaki
    Kurimoto, Makoto
    Takamatsu, Yuichi
    Hori, Yutaro
    Toda, Rei
    Nishio, Takahiro
    Koyama, Yukinori
    Ogiso, Satoshi
    Fukumitsu, Ken
    Ishii, Takamichi
    Taura, Kojiro
    Hatano, Etsuro
    GASTROENTEROLOGY, 2022, 162 (07) : S1283 - S1283